Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-01-06 @ 12:55 PM
Study NCT ID:
NCT00414869
Status:
TERMINATED
Last Update Posted:
2017-02-09
First Post:
2006-12-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
Sponsor:
Forest Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NCXDE05-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None